CardioComm Solutions Inc. Files for FDA for Clearance of GUAVATM II, a New ECG Viewer With ECG Algorithm Technologies

Published: Sep 11, 2012

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, has submitted an application with the U.S. Food and Drug Administration (“FDA”) for clearance of its GUAVATM II ECG viewer technology.

Back to news